Archives
-
Phosphotungstic Acid Negative Stain: Image to Insight
2026-09-22
Phosphotungstic Acid Negative Stain Solution (2%) supports high-contrast electron microscopy of viruses, macromolecules, and cells. This guide explains how morphology imaging can strengthen, but not replace, mechanistic assays of coronavirus glycan-targeting research.
-
5-Azacytidine Reprograms Dormant Cancer Cells
2026-09-21
The 2023 Cell Reports study shows that 5-Azacytidine combined with retinoic acid can reprogram disseminated cancer cells into a stable, non-proliferative state rather than simply eliminating them. The work links this effect to restoration of TGF-β–SMAD4 signaling and provides a framework for studying metastasis suppression through dormancy control.
-
Lambda Protein Phosphatase for BMAL1 Assays
2026-09-21
Lambda Protein Phosphatase enables a more rigorous BMAL1 phosphorylation workflow by separating phosphatase-sensitive regulation from antibody artifacts and phase-separation assay variability. Learn how λ-PPase supports causal, mechanism-aware circadian protein studies.
-
5-Azacytidine Workflows for Epigenetic Assays
2026-09-20
Build more reproducible DNA demethylation, gene-reactivation, and cancer-cell response assays with 5-Azacytidine. This guide connects practical dose–time design with a new PTEN-deficient glioblastoma viral-mimicry study, helping researchers distinguish DNMT-dependent effects from general cytotoxicity.
-
Structure-Guided Proteomimetics Block SARS-CoV-2 Entry
2026-09-19
The reference study introduces a structure-guided proteomimetic strategy for disrupting the difficult SARS-CoV-2 S-RBD/hACE2 protein–protein interaction. By combining stabilized α-helical and cyclic β-sheet mimetics, the lead construct 28 inhibited pseudovirus entry and showed lung epithelial stability with low permeability, supporting further investigation of localized antiviral delivery.
-
InstaBlue Protein Stain Solution Protocol
2026-09-18
InstaBlue Protein Stain Solution provides rapid Coomassie Brilliant Blue visualization of protein bands in polyacrylamide gels without fixation, washing, or destaining. It is suited to routine protein electrophoresis analysis and mass spectrometry workflows, but its stated 5 ng detection level should not be treated as a universal quantitative limit or a replacement for a validated protein quantification assay.
-
5-Azacytidine: From DNMT Trapping to Translation
2026-09-18
5-Azacytidine is more than a DNA demethylation agent: its covalent DNMT trapping can connect epigenetic reprogramming with ATR-mediated DNA damage and apoptosis. This thought-leadership guide translates the mechanism into experimental design, multiple myeloma research, leukemia modeling, and combination-development strategy.
-
DiscoveryProbe Natural Product Library Plus for HTS
2026-09-17
The DiscoveryProbe Natural Product Library Plus connects broad natural-product diversity with a disciplined path from biochemical hit discovery to cell-based validation. Its pre-dissolved format and quality controls make it especially useful for target-led assays, phenotypic profiling, and mechanism-aware antiparasitic drug discovery.
-
ECL Chemiluminescent Substrate Detection Kit (Enhanced)
2026-09-17
The ECL Chemiluminescent Substrate Detection Kit (Enhanced) supports sensitive HRP-based western blot chemiluminescence detection when weak protein signals or low background are important. This guide covers practical setup, imaging, quality control, and troubleshooting; it should not be used to infer biological mechanism or replace validation for non-HRP assays.
-
CD300LD-Targeted mRNA Nanovaccines in HCC
2026-09-16
The reference study develops a cell-membrane-coated liposomal mRNA nanovaccine that targets tumor-associated neutrophils through CD300LD and delivers albumin-fused IL-36γ mRNA. In hepatocellular carcinoma models, this design reprogrammed neutrophil activity, strengthened antitumor immunity, and improved survival, while also defining practical considerations for ex vivo neutrophil validation.
-
5-Azacytidine: Reliable Cell Assay Workflows
2026-09-16
This scenario-based guide explains how 5-Azacytidine, SKU A1907, can improve experimental reasoning around viability, proliferation, cytotoxicity, and DNA methylation studies. It connects documented formulation data with practical controls, dose selection, solvent handling, and interpretation of epigenetic responses.
-
Amitriptyline HCl in BBB Assays
2026-09-15
A practical workflow for using Amitriptyline HCl as a mechanistic probe in receptor studies and surrogate blood–brain barrier transport assays. The approach combines bidirectional permeability testing, MDR1 efflux interpretation, and lysosomal-trapping controls to improve CNS exposure decisions.
-
CHIR 99021 Trihydrochloride in Organoid Design
2026-09-15
A translational perspective on using CHIR 99021 trihydrochloride as a tunable GSK-3 inhibitor for organoid state control, stem cell research, insulin signaling pathway research, and metabolic disease modeling.
-
Tamoxifen Workflows for Recurrent Inflammation
2026-09-14
Tamoxifen provides temporal control for CreER-mediated gene knockout while supporting breast cancer, cell-signaling, and mechanism-focused assays. This workflow connects inducible genetics with the GZMK-driven recurrence model described in a recent airway inflammation study, while emphasizing controls for estrogen-receptor and cytotoxic confounding.
-
GPNMB Model Predicts ESCC Immunotherapy Response
2026-09-14
The reference study identifies circulating soluble GPNMB as both a mechanistically active mediator of PD-1 blockade resistance and a practical biomarker in esophageal squamous cell carcinoma. By integrating plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal framework for response prediction and patient stratification.